Alteration of fibrin clot properties by ultrafine particulate matter

Summary

Both long- and short-term (1–2 hours) exposure to particulate matter (PM) are associated with morbidity and mortality caused by cardiovascular diseases. One of the underlying mechanisms may be due to changes to blood coagulability upon exposure to PM. We investigated this possibility by measuring differences in blood clots formed in the presence of particulate matter in vitro. Total (T)PM increased the permeation of clots in a dose-dependant manner. Filtered (F)PM (17 μg/ml) also produced a significant increase in permeation. Turbidity measured as maximum optical density (ODmax) was increased in a dose-dependant manner with increasing concentration of TPM and FPM. Turbidity measurements also showed a significantly faster rate of polymerisation in the presence of 68 μg/ml FPM. Laser scanning confocal microscopy (LSCM) showed a decrease in fibre density without a significant increase in fibre diameter. However, LSCM showed increased clot heterogeneity due to fibre clustering, creating areas of denser fibrin network surrounded by looser network. The presence of reactive oxygen species (ROS) scavenger mannitol inhibited the effects on fibre clustering. Our data show that TPM and FPM cause alterations in fibrin clot structure, likely through the formation of ROS. These changes in fibrin clot structure may play a role in thromboembolic events upon PM exposure.

Keywords

Fibrinogen - particulate matter - fibrin structure - air pollution - thrombosis

• References

• 1 Atkinson RW, Bremner SA, Anderson HR. et al. Short-term associations between emergency hospital admissions for respiratory and cardiovascular disease and outdoor air pollution in London. Arch. Environ. Health 1999; 54: 398-411.
• 2 Peters A, Dockery DW, Muller JE. et al. Increased particulate air pollution and the triggering of myocardial infarction. Circulation 2001; 103: 2810-2815.
• 3 Peters A. MONICA/KORA-Studiengruppe.. Particles in the outside air increase the risk of cardiovascular diseases. Gesundheitswesen 2005; 67: 79-85.
• 4 Pope CA III, Burnett RT, Thurston GD. et al. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 2004; 109: 71-77.
• 5 Pope CA III, Muhlestein JB, May HT. et al. Ischemic heart disease events triggered by short-term exposure to fine particulate air pollution. Circulation 2006; 114: 2443-2448.
• 6 Miller KA, Siscovick DS, Sheppard L. et al. Long term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med 2007; 356: 458.
• 7 Toren K, Bergdahl IA, Nilsson TK. et al. Occupational exposure to particulate air pollution and mortality due to ischemic heart disease and cerebrovascular disease. Occup. Environ Med 2007; 64: 515-519.
• 8 Peters A, von Klot S, Heier M. et al. Exposure of traffic and the onset of myocardial infarction. N Engl J Med 2004; 351: 1721-1730.
• 9 Weisel JW, Nagaswami C. Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. Biophys J 1992; 63: 111-128.
• 10 Ariëns RAS, Kohler HP, Mansfield MW. et al. Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals: Relation to sex, age, smoking, and hypertension. Arterioscler Thromb Vasc Biol 1999; 19: 2012-2016.
• 11 Bereczky Z, Katona E, Muszbek L. Fibrin stabilization (factor XIII), fibrin structure and thrombosis. Pathophysiol. Haemost Thromb 2003; 33: 430-437.
• 12 Schroeder V, Durrer D, Meili E. et al. Congenital factor XIII deficiency in Switzerland. Swiss Med Wkly 2007; 137: 272-278.
• 13 Woodhead JL, Nagaswami C, Matsuda M. et al. The ultrastructure of fibrinogen caracas II molecules, fibers and clots. J Biol Chem 1996; 271: 4946-4953.
• 14 Marchi R, Lundberg U, Grimbergen J. et al. Fibrinogen Caracas V. an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis. Thromb Haemost 2000; 84: 263-270.
• 15 Lim BCB, Ariëns RAS, Carter AM. et al. Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. Lancet 2003; 361: 1424-1431.
• 16 Standeven KF, Ariëns RA, Grant PJ. The molecular physiology and pathology of fibrin structure/function. Blood Rev 2005; 19: 275-288.
• 17 Collet JP, Moen JL, Veklich YI. et al. The αC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis. Blood 2005; 106: 3824-3830.
• 18 Ajjan R, Grant PJ. Coagulation and atherothrombotic disease. Atherosclerosis 2006; 186: 240-259.
• 19 Fatah K, Silveira A, Tornvall P. et al. Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost 1996; 76: 535-540.
• 20 Collet JP, Allali Y, Lesty C. et al. Altered fibrin architecture is associated with hypofibrinolysis and premature coronary artherothrombosis. Arterioscler Thromb Vasc Biol 2006; 26: 2567-2573.
• 21 Mills JD, Ariëns RAS, Mansfield MW. et al. Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation 2002; 106: 1938-1942.
• 22 Bhasin N, Ariëns RA, West RM. et al. Altered fibrin clot structure and function in the healthy first degree relatives of subjects with intermittent claudication. J Vasc Surg 2008; 78: 1497-1503.
• 23 SRM 1648a – Urban particulate matter. https://www-s.nist.gov/srmors/view_detail.cfm?srm=1648a 2009
• 24 Carter AM, Cymbalista CM, Spector TD. et al. Heritability of clot formation, morphlogy, and lysis. The EuroCLOT Study. Arterioscler Thromb Vasc Biol 2007; 27: 2783-2789.
• 25 Wolberg AS. Thrombin generation and fibrin clot structure. Blood Rev 2007; 21: 131-142.
• 26 Bale MD, Mosher DF. Effects of thrombospondin on fibrin polymerization and structure. J Biol Chem 1986; 261: 862-868.
• 27 Collet JP, Soria J, Mirshahi M. et al. Dusart syndrome: a new concept of the relationship between finrin clot architecture and fibrin clot degradation: hypofibrinolysis related to an abnormal clot structure. Blood 1993; 82: 2462-2469.
• 28 Healey K, Smith EC, Wild CP. et al. The mutagenicity of urban particulate matter in an enzymen free system is associated with the generation of reactive oxygen species. Mutat Res 2006; 602: 1-6.
• 29 Baccarelli A, Zanobetti A, Martinelli I. et al. Effects of exposure to air pollution on blood coagulation. J Thromb Haemost 2007; 05: 252-260.
• 30 Nemmar A, Hoylaerts MF, Hoet PHM. et al. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med 2002; 166: 998-1004.
• 31 Nemmar A, Hoet PH, Dinsdale D. et al. Diesel exhaust particles in lung acutely enhance experimental peripheral thrombosis. Circulation 2003; 107: 1202-1208.
• 32 Lucking AJ, Lundback M, Mills NL. et al. Diesel exhaust inhalation increases thrombus formation in man. Eur Heart J 2008; 29: 3043-3051.
• 33 Takenaka S, Karg E, Roth C. et al. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 2001; 109: 547-551.
• 34 Nemmar A, Vanbilloen H, Hoylaerts MF. et al. Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. Am J Respir Crit Care Med 2001; 164: 1665-1668.
• 35 Zhu MT, Feng WT, Wang Y. et al. Particokinetics and extrapulmonary trans-location of intratracheally instilled ferric oxide nanoparticles in rats and the potential health risk assessment. Toxicol Sci 2009; 107: 345-351.
• 36 Furuyama A, Kanno S, Kobayashi T. et al. Extrapulmonary translocation of intratracheally instilled fine and ultrafine particles via direct and alveolar macrophage-associated routes. Arch Toxicol 2009; 83: 429-437.
• 37 Nemmar A, Hoet PHM, Vanquickenborne B. et al. Passage of inhaled particules into the blood circulation in humans. Circulation 2002; 105: 411-414.
• 38 Mills NL, Amin N, Robinson SD. et al. Do inhaled carbon nanoparticles translocate directly into the circulation in humans. Am J Respir Crit Care Med 2006; 173: 426-431.
• 39 Franklin M, Koutrakis P, Schwartz J. The role of particle composition on the association between PM2.5 and mortality. Epidemiology 2008; 19: 680-689.
• 40 Ayres JG, Borm P, Cassee FR. et al. Evaluating the toxicity of airbourne particulate matter and nanoparticles by measuring oxidative stress potential- a workshop report and consensus statement. Inhal Toxicol 2008; 20: 75-99.
• 41 Kendall M. Fine airborne urban particles (PM2.5) sequester lung surfactant and amino acids from human lung lavage. Am J Physiol Lung Cell Mol Physiol 2007; 293: L1053-L1058.
• 42 Franchini M, Mannucci PM. Short-term effeects of air pollution on cardiovascular diseases: outcomes and mechanisms. J Throm Haemost 2007; 05: 2169-2174.
• 43 Li N, Sioutas C, Cho A. et al. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect 2003; 111: 455-460.
• 44 Becker S, Soukup JM, Gallagher JE. Differential particulate air pollution induced oxidant stress in human granulocytes, monocytes and alveolar macrophages. Toxicol In Vitro 2002; 16: 209-218.
• 45 Avogbe PH, Ayi-Fanou L, Autrup H. et al. Ultrafine particulate matter and high-level benzene urban air pollution in relation to oxidative damage. Carcinogenesis 2005; 26: 613-620.
• 46 de Kok TM, Hogervorst JG, Briede JJ. et al. Genotoxicity and physicochemical characteristics of traffic-relatted ambient particulate matter. Envrion Mol Mutagen 2005; 46: 71-80.
• 47 Dijkgraaf LC, Zargeneta G, Cordewener FW. et al. Crosslinking of fibrinogen and fibronectin by free radicals: A possible initial step in adhesion formation in osteoarthritis of the temporomandibular joint. J Oral Maxillofac Surg 2003; 61: 101-111.
• 48 Undas A, Szuldrzynski K, Stepien E. et al. Reduced clot permeability and susceptability to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress. Atherosclerosis 2007; 196: 551-557.